<DOC>
	<DOC>NCT00159536</DOC>
	<brief_summary>To investigate the effect of metformin on pregnancy complications and pregnancy outcome in the II. and III. trimester of pregnancy in women with polycystic ovary syndrome.</brief_summary>
	<brief_title>Metformin in Pregnant PCOS Women</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>1845 years, PCOS diagnosis according to Rotterdam criteria single, viable, ultrasound verified fetus if metformin was used at conception and early pregnancy, at least 7 days of "wash out" known liver disease or ALAT &gt; 90 nmol/L known renal disease or creatinine &gt; 110 micromol/L diabetes mellitus alcohol or drug abuse peroral steroid treatment cimetidine, anticoagulant or erythromycin treatment at time of inclusion not suitable for other reasons</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>PCOS</keyword>
	<keyword>metformin</keyword>
	<keyword>pregnancy</keyword>
	<keyword>preeclampsia</keyword>
	<keyword>diabetes</keyword>
	<keyword>preterm delivery</keyword>
</DOC>